Stock listing
NGM:CHOSA Chosa Oncology AB Aktie
Home listing (NGM) of Chosa Oncology AB
Follow Chosa Oncology AB into a list and get an email when it puts out news.
- Ticker
- NGM:CHOSA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- NGM
- Currency
- SEK
What changed lately
Latest news release · Jul 15, 2026
Chosa Oncology announces the result of exercise of warrants TO2
Latest news
Financings
New shares on exercise of series TO 2 warrants
Jul 15, 2026 · US$290,782
Closed: SEK 2.8M raised · SEK 0.78 a share · Västra Hamnen Corporate Finance AB +1
Dealers: Västra Hamnen Corporate Finance AB, Nordic Issuing AB
Buyers: Peter Buhl Jensen (CEO) and Ulla Hald Buhl (COO) (377,073 shares); Claus Frisenberg Pedersen (CCO) (173,454 shares); Peter Buhl Jensen and Ulla Hald Buhl (377,073 shares); Claus Frisenberg Pedersen (173,454 shares)
Insiders: Members of the executive management have subscribed for a total of 550,527 shares
Use of proceeds: CLIA laboratory certification, Mount Sinai validation of Platin-DRP in immune oncology, and US commercialization and partnering
Chosa Oncology AB on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 27 in the last 12 months · 33 in all · newest Jul 15, 2026 · oldest 2024
Where Chosa Oncology AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NGM:CHOSA · Home listing · This page | NGM | Sweden | SEK |
| Frankfurt:W5L | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Chosa Oncology AB.